Westfield Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,820,701
Closed -$32.2M 268
2025
Q1
$32.2M Buy
4,820,701
+106,091
+2% +$708K 0.16% 161
2024
Q4
$59.3M Buy
4,714,610
+220,777
+5% +$2.78M 0.26% 124
2024
Q3
$83M Buy
4,493,833
+165,911
+4% +$3.06M 0.38% 84
2024
Q2
$93.2M Buy
4,327,922
+343,892
+9% +$7.4M 0.46% 61
2024
Q1
$107M Buy
3,984,030
+42,171
+1% +$1.14M 0.56% 47
2023
Q4
$118M Sell
3,941,859
-252,137
-6% -$7.56M 0.69% 31
2023
Q3
$85.9M Buy
4,193,996
+538,209
+15% +$11M 0.59% 52
2023
Q2
$72.6M Buy
3,655,787
+419,879
+13% +$8.34M 0.46% 83
2023
Q1
$55.4M Buy
3,235,908
+330,353
+11% +$5.66M 0.39% 101
2022
Q4
$56.9M Buy
2,905,555
+252,353
+10% +$4.94M 0.44% 89
2022
Q3
$42.3M Sell
2,653,202
-700,191
-21% -$11.2M 0.34% 117
2022
Q2
$46.1M Buy
3,353,393
+1,159,668
+53% +$16M 0.36% 98
2022
Q1
$34.8M Buy
2,193,725
+155,734
+8% +$2.47M 0.22% 137
2021
Q4
$44.5M Buy
2,037,991
+11,510
+0.6% +$251K 0.26% 124
2021
Q3
$60.6M Sell
2,026,481
-50,614
-2% -$1.51M 0.37% 103
2021
Q2
$92M Buy
2,077,095
+413,443
+25% +$18.3M 0.55% 60
2021
Q1
$73.8M Buy
1,663,652
+68,671
+4% +$3.05M 0.46% 75
2020
Q4
$87.5M Buy
1,594,981
+96,488
+6% +$5.29M 0.52% 67
2020
Q3
$34.3M Sell
1,498,493
-213,008
-12% -$4.87M 0.22% 131
2020
Q2
$35.8M Buy
1,711,501
+30,067
+2% +$629K 0.25% 122
2020
Q1
$23.5M Buy
1,681,434
+883,838
+111% +$12.3M 0.21% 127
2019
Q4
$18.2M Buy
797,596
+11,482
+1% +$261K 0.13% 169
2019
Q3
$9.16M Buy
786,114
+221,982
+39% +$2.59M 0.07% 188
2019
Q2
$8.46M Buy
+564,132
New +$8.46M 0.06% 197
2018
Q4
Sell
-14,900
Closed -$367K 265
2018
Q3
$367K Buy
+14,900
New +$367K ﹤0.01% 242